The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS) Post author:Shahid Ahmad Post published:March 20, 2020 Post category:Uncategorized An article in USA Today describes certain risks associated with contraction of the COVID-19 coronavirus, specifically the major cause of lethality being Acute Respiratory Distress Syndrome (ARDS). The article can be viewed here. You Might Also Like Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus February 26, 2020 Vasomune Announces FDA Allowance of IND Application for AV-001 for the Treatment of Hospitalized Patients with COVID-19 November 12, 2020 Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference January 15, 2020
Vasomune’s Lead Investigational Medication is Connected to the Fight Against Coronavirus February 26, 2020
Vasomune Announces FDA Allowance of IND Application for AV-001 for the Treatment of Hospitalized Patients with COVID-19 November 12, 2020